VI-0521 Top Dose for pediatric obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Mar 2016: Trial registered, NCT02714062

The trials

NCT02714062: A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents

State
Completed
Phase
Phase 4
People
42 taking part
Started
Mar 2016
Primary completion
Oct 2016
Arms
VI-0521 Top Dose
Results
Posted on the registry
  1. 21 Mar 2016: Trial registered
  2. 5 Feb 2018: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.